Abstract

Molecular subtype classification based on tumor genotype has recently been used for differential diagnosis of breast cancer. The shift from conventional tissue classification to molecular genetics-based classification is primarily because objective genetic information can ensure a biologically clear classification system and patient groups may be created for a given set of diagnoses and suitable treatments. Given the stressful nature of biopsy, radiomic studies are conducted to determine breast cancer subtypes using non-invasive imaging tests. Minimally invasive blood tests using microRNAs (miRNAs) contained in exosomes have been developed. We investigated the usefulness of radiomic features and miRNAs in distinguishing triple-negative breast cancer (TNBC) from other cancer types. Fat suppression T2-weighted magnetic resonance images and miRNAs of 60 cases (9 TNBC and 51 others) were retrieved from the Cancer Genome Atlas Breast Invasive Carcinoma. Six radiomic features and six miRNAs were selected by least absolute shrinkage and selection operator. Linear discriminant analysis was employed to distinguish between TNBC and others. With miRNAs, TNBC and others were completely separated, whereas with radiomic features, TNBC overlapped with other types of breast cancer. Receiver operating characteristic curve analysis results showed that the area under the curve of radiomic features and miRNAs was 0.85 and 1.0, respectively. miRNAs showed a higher discrimination performance than radiomic features. Although gene analysis is expensive and facilities for performing it are limited, miRNAs for blood tests may be useful in artificial intelligence systems for the molecular diagnosis of breast cancer.

Highlights

  • Medical treatment for cancer is performed in the following order: detection of the lesion, differential diagnosis, and treatment

  • With miRNAs, triple-negative breast cancer (TNBC) and others were completely separated, whereas with radiomic features, TNBC overlapped with other types of breast cancer

  • computer-aided diagnosis (CAD) can be classified as an artificial intelligence (AI) system that supports the first half of medical care, and radiomics is an AI system that supports the second half of medical care

Read more

Summary

Introduction

Medical treatment for cancer is performed in the following order: detection of the lesion, differential diagnosis, and treatment. Research on computer-aided diagnosis (CAD) has led to the development of techniques that detect lesions in medical images and distinguish between benign and malignant lesions [1] [2] [3]. Radiomics analyzes the relationship between imaging phenotype and genotype of lesions. Radiomics differs from the CAD research in that it supports the medical process after the detection of lesions. With the progress in post-genome research, the molecular and genetic backgrounds of various cancers have been clarified. This knowledge facilitated molecular classification and aided in the development of molecular-targeted drugs. The possibility to determine the tumor genotype from non-invasive imaging using radiomics would be advantageous

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call